{
  "ticker": "VRTX",
  "year": 2024,
  "quarter": 1,
  "last_updated": "2025-04-19T06:40:54.085766",
  "count": 33,
  "transactions": [
    {
      "id": 19,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "LEIDEN JEFFREY M",
      "reporting_owner_cik": "0001242825",
      "reporting_owner_position": "Executive Chairman",
      "transaction_date": "2024-02-20",
      "transaction_shares": "4118",
      "transaction_price": "420.58",
      "transaction_type": "F",
      "shares_after_transaction": "13778"
    },
    {
      "id": 1,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Sachdev Amit",
      "reporting_owner_cik": "0001406338",
      "reporting_owner_position": "EVP Chief Patient & Ext Af Off",
      "transaction_date": "2024-02-16",
      "transaction_shares": "3498",
      "transaction_price": "424.01",
      "transaction_type": "F",
      "shares_after_transaction": "70866"
    },
    {
      "id": 2,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Bozic Carmen",
      "reporting_owner_cik": "0001790029",
      "reporting_owner_position": "EVP and CMO",
      "transaction_date": "2024-02-16",
      "transaction_shares": "3750",
      "transaction_price": "424.01",
      "transaction_type": "F",
      "shares_after_transaction": "43060"
    },
    {
      "id": 4,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Atkinson Edward Morrow III",
      "reporting_owner_cik": "0001914164",
      "reporting_owner_position": "EVP, Chief Technical Ops. Off.",
      "transaction_date": "2024-02-16",
      "transaction_shares": "1501",
      "transaction_price": "424.01",
      "transaction_type": "F",
      "shares_after_transaction": "21636"
    },
    {
      "id": 5,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Kewalramani Reshma",
      "reporting_owner_cik": "0001735944",
      "reporting_owner_position": "CEO & President",
      "transaction_date": "2024-02-16",
      "transaction_shares": "9359",
      "transaction_price": "424.01",
      "transaction_type": "F",
      "shares_after_transaction": "152912"
    },
    {
      "id": 8,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "WAGNER CHARLES F JR",
      "reporting_owner_cik": "0001223348",
      "reporting_owner_position": "EVP & Chief Financial Officer",
      "transaction_date": "2024-02-16",
      "transaction_shares": "3750",
      "transaction_price": "424.01",
      "transaction_type": "F",
      "shares_after_transaction": "59704"
    },
    {
      "id": 10,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "ALTSHULER DAVID",
      "reporting_owner_cik": "0001550395",
      "reporting_owner_position": "EVP, Global Research and CSO",
      "transaction_date": "2024-02-16",
      "transaction_shares": "3750",
      "transaction_price": "424.01",
      "transaction_type": "F",
      "shares_after_transaction": "43838"
    },
    {
      "id": 16,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Tatsis Ourania",
      "reporting_owner_cik": "0001789815",
      "reporting_owner_position": "EVP, Chief Reg. & Quality Off.",
      "transaction_date": "2024-02-16",
      "transaction_shares": "4499",
      "transaction_price": "424.01",
      "transaction_type": "F",
      "shares_after_transaction": "63680"
    },
    {
      "id": 17,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Arbuckle Stuart A",
      "reporting_owner_cik": "0001557290",
      "reporting_owner_position": "EVP, COO",
      "transaction_date": "2024-02-16",
      "transaction_shares": "4499",
      "transaction_price": "424.01",
      "transaction_type": "F",
      "shares_after_transaction": "71219"
    },
    {
      "id": 24,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "LEIDEN JEFFREY M",
      "reporting_owner_cik": "0001242825",
      "reporting_owner_position": "Executive Chairman",
      "transaction_date": "2024-02-14",
      "transaction_shares": "4356",
      "transaction_price": "419.04",
      "transaction_type": "S",
      "shares_after_transaction": "22551"
    },
    {
      "id": 7,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "LEIDEN JEFFREY M",
      "reporting_owner_cik": "0001242825",
      "reporting_owner_position": "Executive Chairman",
      "transaction_date": "2024-02-12",
      "transaction_shares": "2009",
      "transaction_price": "419.22",
      "transaction_type": "S",
      "shares_after_transaction": "28291"
    },
    {
      "id": 9,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Tatsis Ourania",
      "reporting_owner_cik": "0001789815",
      "reporting_owner_position": "EVP, Chief Reg. & Quality Off.",
      "transaction_date": "2024-02-09",
      "transaction_shares": "2100",
      "transaction_price": "422.74",
      "transaction_type": "F",
      "shares_after_transaction": "68493"
    },
    {
      "id": 11,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Atkinson Edward Morrow III",
      "reporting_owner_cik": "0001914164",
      "reporting_owner_position": "EVP, Chief Technical Ops. Off.",
      "transaction_date": "2024-02-09",
      "transaction_shares": "832",
      "transaction_price": "422.74",
      "transaction_type": "F",
      "shares_after_transaction": "24050"
    },
    {
      "id": 12,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "WAGNER CHARLES F JR",
      "reporting_owner_cik": "0001223348",
      "reporting_owner_position": "EVP & Chief Financial Officer",
      "transaction_date": "2024-02-09",
      "transaction_shares": "2607",
      "transaction_price": "422.74",
      "transaction_type": "F",
      "shares_after_transaction": "63454"
    },
    {
      "id": 18,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Bozic Carmen",
      "reporting_owner_cik": "0001790029",
      "reporting_owner_position": "EVP and CMO",
      "transaction_date": "2024-02-09",
      "transaction_shares": "2100",
      "transaction_price": "422.74",
      "transaction_type": "F",
      "shares_after_transaction": "46810"
    },
    {
      "id": 20,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Arbuckle Stuart A",
      "reporting_owner_cik": "0001557290",
      "reporting_owner_position": "EVP, COO",
      "transaction_date": "2024-02-09",
      "transaction_shares": "3177",
      "transaction_price": "422.74",
      "transaction_type": "F",
      "shares_after_transaction": "80013"
    },
    {
      "id": 21,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Biller Jonathan",
      "reporting_owner_cik": "0001744749",
      "reporting_owner_position": "EVP and Chief Legal Officer",
      "transaction_date": "2024-02-09",
      "transaction_shares": "1588",
      "transaction_price": "422.74",
      "transaction_type": "F",
      "shares_after_transaction": "20018"
    },
    {
      "id": 23,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Kewalramani Reshma",
      "reporting_owner_cik": "0001735944",
      "reporting_owner_position": "CEO & President",
      "transaction_date": "2024-02-09",
      "transaction_shares": "8255",
      "transaction_price": "422.74",
      "transaction_type": "F",
      "shares_after_transaction": "162271"
    },
    {
      "id": 27,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Sachdev Amit",
      "reporting_owner_cik": "0001406338",
      "reporting_owner_position": "EVP Chief Patient & Ext Af Off",
      "transaction_date": "2024-02-09",
      "transaction_shares": "2022",
      "transaction_price": "422.74",
      "transaction_type": "F",
      "shares_after_transaction": "77586"
    },
    {
      "id": 29,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Ambrose Kristen",
      "reporting_owner_cik": "0001856587",
      "reporting_owner_position": "SVP & Chief Accounting Officer",
      "transaction_date": "2024-02-09",
      "transaction_shares": "591",
      "transaction_price": "422.74",
      "transaction_type": "F",
      "shares_after_transaction": "11050"
    },
    {
      "id": 30,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "ALTSHULER DAVID",
      "reporting_owner_cik": "0001550395",
      "reporting_owner_position": "EVP, Global Research and CSO",
      "transaction_date": "2024-02-09",
      "transaction_shares": "2099",
      "transaction_price": "422.74",
      "transaction_type": "F",
      "shares_after_transaction": "50733"
    },
    {
      "id": 25,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "LEIDEN JEFFREY M",
      "reporting_owner_cik": "0001242825",
      "reporting_owner_position": "Executive Chairman",
      "transaction_date": "2024-02-08",
      "transaction_shares": "2698",
      "transaction_price": "421.73",
      "transaction_type": "F",
      "shares_after_transaction": "38348"
    },
    {
      "id": 3,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Bozic Carmen",
      "reporting_owner_cik": "0001790029",
      "reporting_owner_position": "EVP and CMO",
      "transaction_date": "2024-02-06",
      "transaction_shares": "5814",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "35116"
    },
    {
      "id": 6,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Arbuckle Stuart A",
      "reporting_owner_cik": "0001557290",
      "reporting_owner_position": "EVP, COO",
      "transaction_date": "2024-02-06",
      "transaction_shares": "6976",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "63532"
    },
    {
      "id": 13,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "ALTSHULER DAVID",
      "reporting_owner_cik": "0001550395",
      "reporting_owner_position": "EVP, Global Research and CSO",
      "transaction_date": "2024-02-06",
      "transaction_shares": "5814",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "37852"
    },
    {
      "id": 14,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "LEIDEN JEFFREY M",
      "reporting_owner_cik": "0001242825",
      "reporting_owner_position": "Executive Chairman",
      "transaction_date": "2024-02-06",
      "transaction_shares": "10464",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "12887"
    },
    {
      "id": 15,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Atkinson Edward Morrow III",
      "reporting_owner_cik": "0001914164",
      "reporting_owner_position": "EVP, Chief Technical Ops. Off.",
      "transaction_date": "2024-02-06",
      "transaction_shares": "2326",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "16205"
    },
    {
      "id": 22,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Tatsis Ourania",
      "reporting_owner_cik": "0001789815",
      "reporting_owner_position": "EVP, Chief Reg. & Quality Off.",
      "transaction_date": "2024-02-06",
      "transaction_shares": "6976",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "55613"
    },
    {
      "id": 26,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "WAGNER CHARLES F JR",
      "reporting_owner_cik": "0001223348",
      "reporting_owner_position": "EVP & Chief Financial Officer",
      "transaction_date": "2024-02-06",
      "transaction_shares": "5814",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "49507"
    },
    {
      "id": 28,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Biller Jonathan",
      "reporting_owner_cik": "0001744749",
      "reporting_owner_position": "EVP and Chief Legal Officer",
      "transaction_date": "2024-02-06",
      "transaction_shares": "6294",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "16863"
    },
    {
      "id": 31,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Kewalramani Reshma",
      "reporting_owner_cik": "0001735944",
      "reporting_owner_position": "CEO & President",
      "transaction_date": "2024-02-06",
      "transaction_shares": "14516",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "123227"
    },
    {
      "id": 32,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Ambrose Kristen",
      "reporting_owner_cik": "0001856587",
      "reporting_owner_position": "SVP & Chief Accounting Officer",
      "transaction_date": "2024-02-06",
      "transaction_shares": "2950",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "9788"
    },
    {
      "id": 33,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Sachdev Amit",
      "reporting_owner_cik": "0001406338",
      "reporting_owner_position": "EVP Chief Patient & Ext Af Off",
      "transaction_date": "2024-02-06",
      "transaction_shares": "5814",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "64628"
    }
  ]
}